Side-by-side comparison of AI visibility scores, market position, and capabilities
FY2025 (ended Mar 31, 2025): JPY 21.6887T (+6.2%) | Operating Profit: JPY 1.2134T (-12.2%) | FY2024: JPY 20.4286T (+20.8%) | Q3 FY2024 (9 months): Op Profit JPY 1.1399T, margin 7.0% | Auto sales down 297k (Asia impact) | FY2026 guidance: Net profit JPY 250B (-70.1%), Revenue JPY 20.3T (-6.4%)
Honda Motor Co., Ltd. is a Japanese multinational mobility conglomerate founded in 1948 by Soichiro Honda and Takeo Fujisawa in Hamamatsu, Japan. Starting as a motorcycle manufacturer, Honda expanded into automobiles, power equipment, marine engines, and aerospace, becoming one of the largest and most diversified mobility companies in the world. With over 90 million vehicles sold globally and a reputation built on engineering reliability, fuel efficiency, and innovation, Honda operates manufacturing facilities across more than 30 countries on six continents.\n\nHonda's automotive lineup ranges from mass-market sedans and SUVs — including the best-selling Civic and CR-V — to trucks, minivans, and the premium Acura brand. The company is executing a major pivot to electrification through the Honda 0 Series, a new EV architecture designed from the ground up for battery-electric vehicles launching in 2026. Honda's partnership with General Motors on battery technology, combined with its investment in solid-state battery development, reflects a multi-path electrification strategy designed to hedge technology risk while building scale.\n\nHonda reported FY2025 revenue of JPY 21.7 trillion, a 6.2% year-over-year increase, driven by strong North American demand and favorable currency tailwinds. The company faces intensifying competition from Chinese EV manufacturers in Asia and is exploring a potential merger with Nissan as part of broader Japanese automotive consolidation. Honda's engineering culture, global manufacturing scale, and brand credibility in reliability position it as a resilient and well-capitalized incumbent navigating the EV transition.
Aidoc is an AI radiology platform with FDA-cleared algorithms that detect and flag critical findings in medical scans, helping radiologists prioritize urgent cases.
Aidoc is an Israeli-American AI medical imaging company founded in 2016 that has built a comprehensive AI radiology platform with the largest portfolio of FDA-cleared imaging algorithms in the market. The platform integrates with radiology workflow systems to automatically analyze incoming scans, detect critical findings across multiple conditions, and prioritize worklists so radiologists review the most urgent cases first rather than working strictly in order of arrival. Aidoc's algorithms cover a broad range of conditions across multiple anatomical regions including intracranial hemorrhage, pulmonary embolism, incidental pulmonary nodules, and spine fractures. The company raised over $140M and is deployed at over 1,000 healthcare sites worldwide. Aidoc's aiOS platform enables third-party AI algorithms to run alongside its own models, creating an open ecosystem for AI in radiology. The company serves radiology departments seeking to improve throughput, reduce missed findings, and support radiologists managing increasing imaging volumes. Aidoc positions its platform as an AI operating system for radiology rather than a collection of point solutions, enabling comprehensive AI coverage across an entire radiology practice.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.